Back to Search
Start Over
Supplementary Figure 1 from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 1 from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....7e3cd5c5600a7c3ff0d61470189a4156
- Full Text :
- https://doi.org/10.1158/1535-7163.22496464